Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Outpatient Cancer Center
Los Angeles, California, United States
- Sarcoma Oncology Center
Santa Monica, California, United States
- Washington Cancer Institute
Washington D.C., District of Columbia, United States
- Northwestern University
Chicago, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- University of Iowa
Iowa City, Iowa, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Carolinas Hematology Oncology Associates
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2010
- Primary completion
- 30 Jun 2011
- Completion
- 30 Jun 2011
- Last update posted
- 9 Sept 2013
- Registered enrollment
- 5
- Registry id
- NCT01031628
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.